Comparison

TTA-Q6 European Partner

Item no. TMO-T13219-2mg
Manufacturer TargetMol
CASRN 910484-28-5
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C20H15ClF3N3O
Smiles FC(F)(F)CN1C(=O)Nc2ccc(Cl)cc2[C@]1(C1CC1)c1ccc(cc1)C#N
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias Calcium Channel,Calcium Channel
Shipping Condition Cool pack
Available
Manufacturer - Targets
Calcium Channel
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
405.8
Description
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
Pathways
Metabolism|||Membrane transporter/Ion channel
Bioactivity
TTA-Q6 is a selective antagonist of T-type Ca2+ channel, used in the neurological disease.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close